Immunotherapy: Open Access
Open Access

High Impact List of Articles

• Clinical Implications of Anti-CD19 Chimeric Antigen Receptors (CAR) T Cell Therapy in Acute Lymphoblastic Leukemia (ALL)
  Ali R Jazirehi1*, Tam N M Dinh, Zena Taraporewalla, Jahzeel L Paguntalan and Gary J Schiller

  Review Article: Immunotherapy: Open Access

• Aviscumine (ME-503)-Skin Reaction as significant Factor for its Efficacy Expanded Evaluation of the Results from the Phase II Trial NCT00658437 in Patients with Unresectable stage IV Metastatic Melanoma
  Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C. Kähler, Volkmar Jacobi, Klaus Witthohn, Hans Lentzen* and Peter Mohr

  Research Article: Immunotherapy: Open Access

• Facets of Dendritic Cell Function: Who would Think about Cardiovascular Diseases?
  Maja-Theresa Dieterlen and Markus J Barten

  Commentary: Immunotherapy: Open Access

• The Society of Hematologic Oncology (SOHO): Continuing to Move Forward in the Battle against Hematologic Malignancies
  Hagop Kantarjian

  Commentary: Immunotherapy: Open Access

• Atorvastatin-Induced Inhibition of Human Melanoma In Vivo Development
  Teiti Iotefa, Sarrabayrouse Guillaume, Filali Liza, Maisongrosse Véronique, Rochaix Philippe and Tilkin-Mariamé Anne-Françoise

  Research Article: Immunotherapy: Open Access

Conference Proceedings

• Review of virus-like particle production, characterization & comparability for contemporary vaccines
  Michael W Washabaugh

  Scientific Tracks Abstracts: Journal of Antivirals & Antiretrovirals

• Risk perception, HIV/AIDS related knowledge, attitude and practice of the university community in Africa: A case from Ethiopia
  Philipos

  Accepted Abstracts: Journal of Antivirals & Antiretrovirals

Relevant Topics in Immunology & Microbiology